Cargando…
In vitro analysis reveals necroptotic signaling does not provoke DNA damage or HPRT mutations
Most anticancer drugs provoke apoptotic signaling by damaging DNA or other means. Genotoxic therapies may enhance a patient’s risk of developing “therapy-related cancers” due to the accumulation of oncogenic mutations that may occur in noncancerous cells. Mutations can also form upon apoptotic signa...
Autores principales: | Miles, Mark A., Hawkins, Christine J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442655/ https://www.ncbi.nlm.nih.gov/pubmed/32826875 http://dx.doi.org/10.1038/s41419-020-02879-y |
Ejemplares similares
-
Expression variation of OGG1 and HPRT gene and DNA damage in arsenic exposed industrial workers
por: Akram, Zertashia, et al.
Publicado: (2022) -
Impact of nanosilver on various DNA lesions and HPRT gene mutations – effects of charge and surface coating
por: Huk, Anna, et al.
Publicado: (2015) -
Exploding the necroptotic bubble
por: Edry-Botzer, Liat, et al.
Publicado: (2017) -
TRAIL treatment provokes mutations in surviving cells
por: Lovric, M M, et al.
Publicado: (2010) -
Metabolism-Related Bioinformatics Analysis Reveals That HPRT1 Facilitates the Progression of Oral Squamous Cell Carcinoma In Vitro
por: Ye, Hengyu, et al.
Publicado: (2022)